I nostri risultati svelano meccanismi indipendenti da Gb3 nella progressione della malattia di Fabry e aprono la strada a nuove procedure diagnostiche...

Biomarcatori plasmatici come MCP-1, YKL-40 e Cistatina C offrono nuove prospettive sul monitoraggio della malattia di Fabry.

Questo studio evidenzia il potenziale del NBGS nel favorire la diagnosi precoce di LSD presintomatiche, permettendo interventi tempestivi e migliori...

We aimed to examine specialist palliative care (SPC) involvement and end-of-life care for patients with MM

This study will help optimize the delivery of safe, low-cost, and scalable telehealth exercise interventions to improve health outcomes in patients...

This retrospective cohort study used 2013-2018 commercial and Medicare claims data to assess medication use in adults with MM

To evaluate impact of time to transplant on subsequent outcomes, we analyzed data on consecutive MM patients who received novel agents-based induction...

The LR classifier performed better than the other classifiers based on different data (AUC: 0.65-0.82; P < 0.05)

Despite the introduction of new and better treatments, rapidly implemented in our countries, our registries uncover subgroups of patients that still...

This is a new concept toward individualized treatment in multiple myeloma

Our study demonstrates that pre-existing hypertension was significantly associated with a lower PFS in newly diagnosed MM patients